OBJECTIVES: To investigate the combined influence of blood flow and haemodilution with either a miniaturized (Mini-CPB) or a conventional cardiopulmonary bypass (C-CPB) circuit on average oxygen delivery during bypass. The influence of this on clinical outcome, particularly renal dysfunction after routine coronary artery bypass surgery (CABG), was measured. METHODS: Retrospective analysis in two groups of 160 patients based on the surgeon's preference for bypass circuit. We compared consecutive patients undergoing isolated CABG surgery by two surgeons using Mini-CPB with a matched cohort of patients, from the same period, undergoing isolated CABG surgery by four other surgeons using a C-CPB. No trial-related intervention occurred. Data on bypass circuit parameters and clinical outcomes were acquired from routinely collected data sources. RESULTS: Average cardiopulmonary bypass pump flow was significantly lower with Mini-CPB compared with C-CPB. Mini-CPB resulted in significantly less haemodilution. The resultant calculated average oxygen delivery provided by the two systems was the same. Percentage change in plasma creatinine was significantly and inversely related to the oxygen delivery during CPB. There was no difference in percentage change in plasma creatinine between groups. The risk of having Acute Kidney Injury Network (AKIN) score ≥ 1 increased 1% for every 1 ml min(-1) m(-2) decrease in oxygen delivery (P = 0.0001, OR 0.990, 95% CI 0.984-0.995). CONCLUSIONS: Despite aiming for the same target pump flow, periodic limitations of venous return to the pump resulted in a significant reduction in average flow delivered to the patient by Mini-CPB. Less haemodilution compensated for this reduction, so that the average oxygen delivery was the same. The association between oxygen delivery and postoperative change in plasma creatinine was evident in both groups. Further work to understand whether there is a particular cohort of patients who benefit (or are put at risk) by one method of CPB vs the other is warranted.
OBJECTIVES: To investigate the combined influence of blood flow and haemodilution with either a miniaturized (Mini-CPB) or a conventional cardiopulmonary bypass (C-CPB) circuit on average oxygen delivery during bypass. The influence of this on clinical outcome, particularly renal dysfunction after routine coronary artery bypass surgery (CABG), was measured. METHODS: Retrospective analysis in two groups of 160 patients based on the surgeon's preference for bypass circuit. We compared consecutive patients undergoing isolated CABG surgery by two surgeons using Mini-CPB with a matched cohort of patients, from the same period, undergoing isolated CABG surgery by four other surgeons using a C-CPB. No trial-related intervention occurred. Data on bypass circuit parameters and clinical outcomes were acquired from routinely collected data sources. RESULTS: Average cardiopulmonary bypass pump flow was significantly lower with Mini-CPB compared with C-CPB. Mini-CPB resulted in significantly less haemodilution. The resultant calculated average oxygen delivery provided by the two systems was the same. Percentage change in plasma creatinine was significantly and inversely related to the oxygen delivery during CPB. There was no difference in percentage change in plasma creatinine between groups. The risk of having Acute Kidney Injury Network (AKIN) score ≥ 1 increased 1% for every 1 ml min(-1) m(-2) decrease in oxygen delivery (P = 0.0001, OR 0.990, 95% CI 0.984-0.995). CONCLUSIONS: Despite aiming for the same target pump flow, periodic limitations of venous return to the pump resulted in a significant reduction in average flow delivered to the patient by Mini-CPB. Less haemodilution compensated for this reduction, so that the average oxygen delivery was the same. The association between oxygen delivery and postoperative change in plasma creatinine was evident in both groups. Further work to understand whether there is a particular cohort of patients who benefit (or are put at risk) by one method of CPB vs the other is warranted.
Authors: Keyvan Karkouti; George Djaiani; Michael A Borger; William S Beattie; Ludwik Fedorko; Duminda Wijeysundera; Joan Ivanov; Jacek Karski Journal: Ann Thorac Surg Date: 2005-10 Impact factor: 4.330
Authors: G R DeFoe; C S Ross; E M Olmstead; S D Surgenor; M P Fillinger; R C Groom; R J Forest; J W Pieroni; C S Warren; M E Bogosian; C F Krumholz; C Clark; R A Clough; P W Weldner; S J Lahey; B J Leavitt; C A Marrin; D C Charlesworth; P Marshall; G T O'Connor Journal: Ann Thorac Surg Date: 2001-03 Impact factor: 4.330
Authors: W C Fang; R E Helm; K H Krieger; T K Rosengart; W J DuBois; C Sason; M L Lesser; O W Isom; J P Gold Journal: Circulation Date: 1997-11-04 Impact factor: 29.690
Authors: K Karkouti; W S Beattie; D N Wijeysundera; V Rao; C Chan; K M Dattilo; G Djaiani; J Ivanov; J Karski; T E David Journal: J Thorac Cardiovasc Surg Date: 2005-02 Impact factor: 5.209
Authors: Robert H Habib; Anoar Zacharias; Thomas A Schwann; Christopher J Riordan; Samuel J Durham; Aamir Shah Journal: J Thorac Cardiovasc Surg Date: 2003-06 Impact factor: 5.209
Authors: Madhav Swaminathan; Barbara G Phillips-Bute; Peter J Conlon; Peter K Smith; Mark F Newman; Mark Stafford-Smith Journal: Ann Thorac Surg Date: 2003-09 Impact factor: 4.330
Authors: Rien A J M Huybregts; Aurora M Morariu; Gerhard Rakhorst; Stefan R Spiegelenberg; Hans W A Romijn; Roel de Vroege; Willem van Oeveren Journal: Ann Thorac Surg Date: 2007-05 Impact factor: 4.330
Authors: M Ranucci; M Pavesi; E Mazza; C Bertucci; A Frigiola; L Menicanti; A Ditta; A Boncilli; D Conti Journal: Perfusion Date: 1994 Impact factor: 1.972
Authors: Marco Ranucci; Barbara De Toffol; Giuseppe Isgrò; Federica Romitti; Daniela Conti; Maira Vicentini Journal: Crit Care Date: 2006 Impact factor: 9.097
Authors: Marco Ranucci; Giovanni Carboni; Mauro Cotza; Paolo Bianchi; Umberto Di Dedda; Tommaso Aloisio Journal: PLoS One Date: 2015-05-18 Impact factor: 3.240